Benefits of Myricetin on Diabetes and Obesity: Advance on the Most Recent Research From 2021 to 2025
Phytochemicals in Food and Medicine · 2026-03 · 1 (1)
DOI: 10.1002/pfm2.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemicals in Food and Medicine, online erschienen am 31.03.2026. Verfasst von Jianbo Xiao. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Myricetin, a typical favonol in food and medicine, has attracted widespread attention, with many new research papers published every year. This mini‐review highlights the most recent research on myricetin from 2021 to 2025. In the past 5 years, several myricetin or its O ‐glycosides were studied from its natural resources. The benefits of myricetin mostly focus on its effects on diabetes and obesity in vivo. The effect of interaction between myricetin and gut microflora on the management of diabetes and obesity has been one of the growing hot topics. More practice is needed to develop functional foods related to myricetin.
Zitieren
APA
Xiao, J. (2026). Benefits of Myricetin on Diabetes and Obesity: Advance on the Most Recent Research From 2021 to 2025. Phytochemicals in Food and Medicine, 1(1). https://doi.org/10.1002/pfm2.70004
Vancouver
Xiao J. Benefits of Myricetin on Diabetes and Obesity: Advance on the Most Recent Research From 2021 to 2025. Phytochemicals in Food and Medicine. 2026;1(1). doi:10.1002/pfm2.70004
BibTeX
@article{Xiao2026,
author = {Xiao, Jianbo},
title = {Benefits of Myricetin on Diabetes and Obesity: Advance on the Most Recent Research From 2021 to 2025},
journal = {Phytochemicals in Food and Medicine},
year = {2026},
volume = {1},
number = {1},
doi = {10.1002/pfm2.70004}
}
EUVIMED